STOCK TITAN

[Form 4] Virios Therapeutics, Inc. Common Stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On June 24, 2025, First Bancorp (FBNC) Chief Operating Officer Christian A. Wilson reported the award of 3,028 shares of common stock under the company’s Long Term Incentive Plan at a deemed price of $42.12 per share. The shares will vest on June 24, 2028. After the grant, Wilson’s direct ownership rose to 8,463 shares. No derivative securities or open-market purchases were disclosed, and the transaction involves no immediate cash outflow. Overall, the filing documents a routine equity incentive that modestly tightens executive-shareholder alignment without signaling near-term changes to First Bancorp’s financial position.

Il 24 giugno 2025, il Chief Operating Officer di First Bancorp (FBNC), Christian A. Wilson, ha comunicato l'assegnazione di 3.028 azioni ordinarie nell'ambito del Piano di Incentivi a Lungo Termine della società, con un prezzo convenzionale di 42,12 $ per azione. Le azioni matureranno il 24 giugno 2028. Dopo l'assegnazione, la proprietà diretta di Wilson è aumentata a 8.463 azioni. Non sono stati rivelati titoli derivati né acquisti sul mercato aperto, e l'operazione non comporta alcuna uscita di cassa immediata. Nel complesso, il documento descrive un incentivo azionario di routine che rafforza leggermente l'allineamento tra dirigenti e azionisti senza indicare cambiamenti a breve termine nella situazione finanziaria di First Bancorp.

El 24 de junio de 2025, el Director de Operaciones de First Bancorp (FBNC), Christian A. Wilson, informó la concesión de 3.028 acciones ordinarias bajo el Plan de Incentivos a Largo Plazo de la compañía, a un precio considerado de $42.12 por acción. Las acciones se consolidarán el 24 de junio de 2028. Tras la concesión, la propiedad directa de Wilson aumentó a 8.463 acciones. No se divulgaron valores derivados ni compras en el mercado abierto, y la transacción no implica un desembolso de efectivo inmediato. En general, el documento refleja un incentivo de capital rutinario que ajusta modestamente la alineación entre ejecutivos y accionistas sin señalar cambios a corto plazo en la posición financiera de First Bancorp.

2025년 6월 24일, First Bancorp(FBNC)의 최고운영책임자(COO) Christian A. Wilson은 회사의 장기 인센티브 계획(Long Term Incentive Plan)에 따라 3,028주의 보통주를 주당 42.12달러의 평가 가격으로 부여받았다고 보고했습니다. 이 주식은 2028년 6월 24일에 확정됩니다. 부여 후 Wilson의 직접 소유 주식은 8,463주로 증가했습니다. 파생 증권이나 공개 시장 매입은 공개되지 않았으며, 이번 거래는 즉각적인 현금 유출을 수반하지 않습니다. 전반적으로 이 보고서는 경영진과 주주 간의 이해관계를 다소 강화하는 일상적인 주식 인센티브를 기록하며, First Bancorp의 단기 재무 상태에 변화가 있음을 시사하지 않습니다.

Le 24 juin 2025, le Directeur des opérations de First Bancorp (FBNC), Christian A. Wilson, a déclaré l'attribution de 3 028 actions ordinaires dans le cadre du Plan d'incitation à long terme de la société, à un prix estimé de 42,12 $ par action. Les actions seront acquises le 24 juin 2028. Après cette attribution, la détention directe de Wilson est passée à 8 463 actions. Aucun titre dérivé ni achat sur le marché ouvert n'ont été divulgués, et la transaction n'entraîne aucune sortie de trésorerie immédiate. Globalement, le document décrit une incitation en actions routinière qui renforce modestement l'alignement entre les dirigeants et les actionnaires sans indiquer de changements à court terme dans la situation financière de First Bancorp.

Am 24. Juni 2025 berichtete der Chief Operating Officer von First Bancorp (FBNC), Christian A. Wilson, über die Zuteilung von 3.028 Stammaktien im Rahmen des langfristigen Anreizplans des Unternehmens zu einem angenommenen Preis von 42,12 $ pro Aktie. Die Aktien werden am 24. Juni 2028 fällig. Nach der Zuteilung stieg Wilsons direkter Aktienbesitz auf 8.463 Aktien. Es wurden keine Derivate oder Käufe am offenen Markt offengelegt, und die Transaktion verursacht keinen sofortigen Geldabfluss. Insgesamt dokumentiert die Meldung eine routinemäßige Aktienvergütung, die die Ausrichtung zwischen Führungskräften und Aktionären leicht verstärkt, ohne kurzfristige Veränderungen der finanziellen Lage von First Bancorp anzudeuten.

Positive
  • 3,028-share LTIP award increases insider ownership to 8,463 shares, enhancing alignment between management and shareholders.
Negative
  • None.

Insights

TL;DR: Routine LTIP grant adds 3,028 shares to COO’s stake; limited dilution, negligible near-term impact, slight positive alignment signal.

The Form 4 reflects a non-derivative equity award, not an open-market buy, so cash expenditure is zero and dilution, while real, is de minimis relative to the company’s total share count (not provided in the filing). Wilson’s ownership climbs to 8,463 shares, a modest but directionally positive change that can strengthen management’s long-term incentive to grow shareholder value. Because the shares vest over three years, the accounting expense will be recognized over that period. In isolation, the event is neutral for valuation but may be viewed favorably by governance-minded investors.

TL;DR: Standard equity incentive, vesting in 2028, aligns executive interests; not an open-market buy, so market response should remain muted.

From a governance standpoint, the award is consistent with best-practice incentive structuring—time-based vesting encourages retention and long-term focus. No Rule 10b5-1 designation is indicated, and no simultaneous sales were reported, reducing concerns about opportunistic timing. Because the grant size is modest for a C-suite officer, shareholder dilution risk is minimal. Overall, the disclosure is routine and does not materially alter the firm’s governance risk profile.

Il 24 giugno 2025, il Chief Operating Officer di First Bancorp (FBNC), Christian A. Wilson, ha comunicato l'assegnazione di 3.028 azioni ordinarie nell'ambito del Piano di Incentivi a Lungo Termine della società, con un prezzo convenzionale di 42,12 $ per azione. Le azioni matureranno il 24 giugno 2028. Dopo l'assegnazione, la proprietà diretta di Wilson è aumentata a 8.463 azioni. Non sono stati rivelati titoli derivati né acquisti sul mercato aperto, e l'operazione non comporta alcuna uscita di cassa immediata. Nel complesso, il documento descrive un incentivo azionario di routine che rafforza leggermente l'allineamento tra dirigenti e azionisti senza indicare cambiamenti a breve termine nella situazione finanziaria di First Bancorp.

El 24 de junio de 2025, el Director de Operaciones de First Bancorp (FBNC), Christian A. Wilson, informó la concesión de 3.028 acciones ordinarias bajo el Plan de Incentivos a Largo Plazo de la compañía, a un precio considerado de $42.12 por acción. Las acciones se consolidarán el 24 de junio de 2028. Tras la concesión, la propiedad directa de Wilson aumentó a 8.463 acciones. No se divulgaron valores derivados ni compras en el mercado abierto, y la transacción no implica un desembolso de efectivo inmediato. En general, el documento refleja un incentivo de capital rutinario que ajusta modestamente la alineación entre ejecutivos y accionistas sin señalar cambios a corto plazo en la posición financiera de First Bancorp.

2025년 6월 24일, First Bancorp(FBNC)의 최고운영책임자(COO) Christian A. Wilson은 회사의 장기 인센티브 계획(Long Term Incentive Plan)에 따라 3,028주의 보통주를 주당 42.12달러의 평가 가격으로 부여받았다고 보고했습니다. 이 주식은 2028년 6월 24일에 확정됩니다. 부여 후 Wilson의 직접 소유 주식은 8,463주로 증가했습니다. 파생 증권이나 공개 시장 매입은 공개되지 않았으며, 이번 거래는 즉각적인 현금 유출을 수반하지 않습니다. 전반적으로 이 보고서는 경영진과 주주 간의 이해관계를 다소 강화하는 일상적인 주식 인센티브를 기록하며, First Bancorp의 단기 재무 상태에 변화가 있음을 시사하지 않습니다.

Le 24 juin 2025, le Directeur des opérations de First Bancorp (FBNC), Christian A. Wilson, a déclaré l'attribution de 3 028 actions ordinaires dans le cadre du Plan d'incitation à long terme de la société, à un prix estimé de 42,12 $ par action. Les actions seront acquises le 24 juin 2028. Après cette attribution, la détention directe de Wilson est passée à 8 463 actions. Aucun titre dérivé ni achat sur le marché ouvert n'ont été divulgués, et la transaction n'entraîne aucune sortie de trésorerie immédiate. Globalement, le document décrit une incitation en actions routinière qui renforce modestement l'alignement entre les dirigeants et les actionnaires sans indiquer de changements à court terme dans la situation financière de First Bancorp.

Am 24. Juni 2025 berichtete der Chief Operating Officer von First Bancorp (FBNC), Christian A. Wilson, über die Zuteilung von 3.028 Stammaktien im Rahmen des langfristigen Anreizplans des Unternehmens zu einem angenommenen Preis von 42,12 $ pro Aktie. Die Aktien werden am 24. Juni 2028 fällig. Nach der Zuteilung stieg Wilsons direkter Aktienbesitz auf 8.463 Aktien. Es wurden keine Derivate oder Käufe am offenen Markt offengelegt, und die Transaktion verursacht keinen sofortigen Geldabfluss. Insgesamt dokumentiert die Meldung eine routinemäßige Aktienvergütung, die die Ausrichtung zwischen Führungskräften und Aktionären leicht verstärkt, ohne kurzfristige Veränderungen der finanziellen Lage von First Bancorp anzudeuten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gendreau Roger Michael

(Last) (First) (Middle)
C/O DOGWOOD THERAPEUTICS, INC.
44 MILTON AVENUE

(Street)
ALPHARETTA GA 30009

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Dogwood Therapeutics, Inc. [ DWTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF MEDICAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $4.71 06/27/2025 A 12,075 (1) 06/27/2035 Common Stock 12,075 $0 12,075 D
Explanation of Responses:
1. The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.
/s/ Greg Duncan, Attorney-in-Fact 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did FBNC report on Form 4 dated June 24, 2025?

The filing reports a grant of 3,028 shares of common stock to COO Christian A. Wilson under the Long Term Incentive Plan.

How many First Bancorp shares were granted to COO Christian Wilson?

Wilson received 3,028 shares of FBNC common stock.

When will the newly granted FBNC shares vest?

The shares are scheduled to vest on June 24, 2028.

What is Christian Wilson's total direct FBNC share ownership after the grant?

Following the transaction, Wilson directly owns 8,463 shares of First Bancorp.

Were any derivative securities involved in this Form 4 filing?

No, the Form 4 indicates no derivative security activity.
Virios Therapeutics, Inc.

NASDAQ:VIRI

VIRI Rankings

VIRI Latest News

VIRI Latest SEC Filings

VIRI Stock Data

4.30M
27.76M
1.69%
Biotechnology
Pharmaceutical Preparations
Link
United States
ALPHARETTA